Flow Cytometry Market: Global Industry Analysis and Forecast (2023-2029)

Flow Cytometry Market was valued at US$ 31.31 Bn. in 2022. Global Flow Cytometry Market size is expected to grow at a CAGR of 8% through the forecast period.
Flow Cytometry Market Overview:
With regard to describing and distinguishing various cell types in a heterogeneous cell population, measuring cell size and volume, and determining the purity of isolated subpopulations, flow cytometry is a commonly used technique. This enables the simultaneous examination of several parameters for a single cell. It is used to quantify the amount of fluorescence that fluorescently-labelled antibodies emit when they identify proteins and ligands that bind to certain compounds found in cells, such as DNA and propidium iodide. Following the staining step, cells are placed in tubes or microtiter plates and incubated with unlabelled or fluorescently-labelled antibodies before being analysed on a flow cytometer. The growing use of flow cytometry in several research and diagnostic applications, together with technical improvements, is driving the market's growth. The introduction of flow cytometry technology in cutting-edge research fields like cytogenomics, proteomics, and marine biology also contributes to the growth of the flow cytometry market.To know about the Research Methodology:-Request Free Sample Report

2022 is considered as a base year to forecast the market from 2023 to 2029. 2022’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029. 2022 is a year of exception and analysis especially with the impact of lockdown by region.

Flow Cytometry COVID 19 Insights:

The COVID-19 epidemic inspired researchers all across the world to take action. Flow cytometry has been utilised in a number of investigations to look into how the immune system responds to SARS-CoV-2.

For example, researchers discovered using flow cytometry that COVID-19 patients' B-cell and T-cell frequencies were lower than those of recovered donors and healthy donors.

In a different study, researchers used a flow-cytometric bead array (C19BA) to simultaneously test for the presence of IgG and IgM antibodies against three viral antigens in order to determine seroconversion against the SARS-CoV-2 virus. This method revealed N-reactive antibodies in a cohort of samples taken before the pandemic, demonstrating the existence of cross-reactivity against this conserved viral protein.

According to an interview with scientists from Thermo Fisher Scientific, Inc. (US), the University of California requested participants for a significant project regarding researching the impacts of SARS-CoV-2 from researchers, nurses, and doctors. Using other flow cytometry analyzers, such as the Attune NxT Flow Cytometer, the researchers analysed blood samples using purified proteins and antibody panels. Since numerous COVID-19 research projects employ flow cytometry technologies to examine how the immune system responds to SARS-CoV-2, the COVID-19 pandemic has thus had a favourable effect on this market.
Flow Cytometry Market Dynamics:
Drivers:

The increasing incidence and prevalence of HIV/AIDS and cancer worldwide, the growing use of flow cytometry techniques in academic and research settings, the growth of public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, the increasing integration of AI platforms into flow cytometry workflows, and improvements in flow cytometry software all contribute to the market's growth. However, one important issue impeding the market's growth is the high cost of flow cytometry devices.

During drug research and development procedures, flow cytometry has become a crucial technique for safety and exploratory objectives. This technique is employed from target discovery and screening through pre-clinical studies. In a short amount of time, flow cytometry can assess a huge number of particles and deliver statistically reliable data regarding cell populations. These capabilities, together with its multi-parametric methodology, make flow cytometry an ideal tool for drug discovery and development in the pharmaceutical and biopharmaceutical sectors.

Additionally, biomarker research has become a crucial component in developing new drugs. It offers helpful information to assist in clinical choices, evaluates the pharmacodynamics of medications, and aids in the submission of drug applications to regulatory agencies. Additionally, this boosts a drug's market value and expedites its development. The analysis of target engagement and biomarker expression in cells, as well as the evaluation of cell activities and signalling events, are all tasks that flow cytometry is frequently utilised for in biomarker research. This market is growing as a result of an increase in clinical trials and the use of flow cytometry in a variety of research applications.

Restraints:

The overall rise in the total cost of ownership of these instruments is brought on by maintenance charges as well as a number of other indirect expenditures. Therefore, expensive product installation costs and other related factors impede the best use of flow cytometry devices in clinical and research settings, particularly in developing countries. Furthermore, flow cytometry devices are costly because they include sophisticated features and functions. Cell sorters using flow cytometry are more costly than cell analyzers, nevertheless.

The preference of end users for less expensive cell and genomic analysis techniques (such as microscopy, spectroscopy, PCR, and NGS), particularly among independent researchers, small CROs, and emerging pharmaceutical and biotechnology companies, also limits demand for expensive flow cytometry equipment and reagents. Because of this, it is forecast that the availability of alternative techniques and considerable product costs will both limit the growth of the flow cytometry market throughout the forecast period.

Opportunities:

Major companies in the worldwide flow cytometry market have several prospects for growth in nations like China, Japan, India, and South Korea. The growth of research initiatives across important nations; the absence of significant regulatory obstacles; the ongoing development of healthcare infrastructures; the rise in patient numbers and costs; and the growth of market leaders' distribution networks in these areas are all factors that contribute to these growth opportunities. Additionally, because there are fewer strict laws and data requirements in the Asia-Pacific region, regulatory policies there are more flexible and business-friendly. This has further compelled major market participants to concentrate on emerging nations, combined with rising rivalry in existing markets.

China, for example, has a robust healthcare system, a quick-growing economy, growing domestic demand, and public-private efforts that encourage research. The target illnesses are becoming more common in India as well, and the country's life science research sector is growing quickly. For market participants active throughout the forecast period, the development potential provided by growing nations, together with the growing product range and distribution networks of leading companies, is forecast to present fresh growth prospects.

Challenges:

Target molecules are taken on by reagents like antibodies, fixatives, permeabilization buffers, and dyes. Since there are now few reagents available for examining cells from solid tissues, more reagents must be created.

However, the creation of a novel, efficient reagent is a difficult process that involves a number of difficulties, including variations in fluorescence intensity and marker expression levels, problems with the stability of some fluorophores, and problems with optical background (caused by significant emission spillover from non-primary fluorescent reagents) (Source: Becton, Dickinson and Company-White Paper). Given this, it can be inferred that one of the major difficulties suppliers in the market for flow cytometry reagents confront is the creation of reagents.
Flow Cytometry Market Segment Analysis:
Based on Component:

Due to the development of novel instrument designs, the demand for highly efficient replaceable components, applications in the treatment of newer diseases, and an increase in research and developments in flow cytometry techniques, the instruments segment held the largest market share by component in 2022. Reagents and consumables are forecast to emerge as the leading category since they are necessary in flow cytometry analysis. Due to the combination of imaging capabilities and reagent consumption for enhancing the instrument performance and making it more affordable for emerging countries, the market share for flow cytometry reagents is forecast to increase.

Based on the Technology:

The bead-based flow cytometry market is forecast to develop at the quickest rate in terms of technology due to its widespread usage in research applications, shorter analysis times, and ability to analyse several samples at once. However, the cell-based flow cytometry category generates the most income due to its widespread use in the diagnosis of several illnesses, including cancer and HIV, biomedical research, and its growing usage in tracking the effectiveness of medication therapy.

Based on the Application:

Due to a growth in research into academic and clinical applications of flow cytometry, the academic and clinical applications category accounted for a sizable portion of the market share in the flow cytometry market in 2022. However, due to the increased usage of technology in diagnostic applications, the sector for diagnostic applications is forecast to develop rapidly.

Based on the End-User:

Due to significant investments in R&D activities, developments in cell-and bead-based technologies, a growing patient population, and rising demand for flow cytometry in the drug discovery process, the commercial organisations segment accounted for a sizable portion of the flow cytometry market by end user in 2022. Due to a surge in innovative clinical applications, immunoassay procedures, and varied uses of flow cytometry in disease detection, this market is forecast to develop at a rapid rate.
Regional Insights:
The North-America region dominated the market with 40 % share in 2022. The flow cytometry market's revenue in 2022 was dominated by North America. Rapid technical improvements, rising R&D spending, a growing patent pool, and an increase in applications all contribute to the growth of the flow cytometry market in North America.

The Asia-Pacific region is expected to witness significant growth at a CAGR of 8% through the forecast period. The Asia-Pacific flow cytometry industry is forecast to emerge as the leading market. This is mostly attributable to large multinational corporations outsourcing their research procedures to CROs in the Asia-Pacific region. In addition, the growing demand for advanced healthcare facilities and the prevalence of chronic illnesses like cancer and HIV are forecast to fuel the growth of the flow cytometry market.

The objective of the report is to present a comprehensive analysis of the global Flow Cytometry Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Flow Cytometry Market dynamic, structure by analyzing the market segments and projecting the Flow Cytometry Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Flow Cytometry Market make the report investor’s guide.
Flow Cytometry Market Scope: Inquire before buying



Flow Cytometry Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US$ 9.48 Bn.


Forecast Period 2023 to 2029 CAGR:
8%
Market Size in 2029:
US$ 31.31 Bn.


 Segments Covered:
by Component
Instruments
Reagents and consumables
Software
Services


by Technology
Cell based flow cytometry
Bead based flow cytometry


by Application
Academic and clinical applications
Diagnostic applications


by End-User
Hospitals
Medical schools and clinical testing labs
Commercial organizations
Academic institutions



Flow Cytometry Market by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players
1. Agilent Technologies, Inc.
2. Becton Dickinson and Company
3. bioMérieux SA
4. Bio-Rad Laboratories, Inc.
5. Danaher Corporation
6. DiaSorin S.p.A.
7. Miltenyi Biotec, Inc.
8. Sartorius AG
9. Sysmex Corporation
10. Thermo Fisher Scientific Inc.

Frequently Asked Questions:

1] What segments are covered in the Global Flow Cytometry Market report?
Ans. The segments covered in the Flow Cytometry Market report are based on Component, Technology, Application and End User.

2] Which region is expected to hold the highest share in the Global Flow Cytometry Market?
Ans. The North America region is expected to hold the highest share in the Flow Cytometry Market.

3] What is the market size of the Global Flow Cytometry Market by 2029?
Ans. The market size of the Flow Cytometry Market by 2029 is expected to reach US$ 31.31Bn.

4] What is the forecast period for the Global Flow Cytometry Market?
Ans. The forecast period for the Flow Cytometry Market is 2023-2029.

5] What was the market size of the Global Flow Cytometry Market in 2022?
Ans. The market size of the Flow Cytometry Market in 2022 was valued at US$ 9.48 Bn.